The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCA BIOPHARMA INC | COM | 00211Y506 | 1,420,929 | 706,930 | SH | SOLE | 0 | 0 | 706,930 | |||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 5,872,500 | 3,915,000 | SH | SOLE | 0 | 0 | 3,915,000 | |||
| ASTROTECH CORP | COM | 046484309 | 2,226,141 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | |||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 14,400,000 | 4,800,000 | SH | SOLE | 0 | 0 | 4,800,000 | |||
| ATHIRA PHARMA INC | COM | 04746L104 | 3,442,811 | 1,704,362 | SH | SOLE | 0 | 0 | 1,704,362 | |||
| AVROBIO INC | COM | 05455M100 | 6,162,506 | 4,001,627 | SH | SOLE | 0 | 0 | 4,001,627 | |||
| LISATA THERAPEUTICS INC | COM | 128058302 | 521,815 | 243,839 | SH | SOLE | 0 | 0 | 243,839 | |||
| CYTEIR THERAPEUTICS INC | COM | 23284P103 | 9,230,023 | 3,250,008 | SH | SOLE | 0 | 0 | 3,250,008 | |||
| ELIEM THERAPEUTICS INC | COM | 28658R106 | 5,097,632 | 1,938,263 | SH | SOLE | 0 | 0 | 1,938,263 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 683,000 | 50,000 | SH | SOLE | 0 | 0 | 50,000 | |||
| FORTE BIOSCIENCES INC | COM | 34962G109 | 1,166,247 | 1,761,702 | SH | SOLE | 0 | 0 | 1,761,702 | |||
| CALCIMEDICA INC | COM NEW | 38942Q202 | 236,113 | 88,781 | SH | SOLE | 0 | 0 | 88,781 | |||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 443,880 | 108 | SH | Put | SOLE | 0 | 0 | 108 | ||
| ISHARES TR | 0-3 MNTH TREASRY | 46436E718 | 27,180,900 | 270,000 | SH | SOLE | 0 | 0 | 270,000 | |||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 844,750 | 272,500 | SH | SOLE | 0 | 0 | 272,500 | |||
| NEOLEUKIN THERAPEUTICS INC | COM NEW | 64049K203 | 389,723 | 98,664 | SH | SOLE | 0 | 0 | 98,664 | |||
| NEXTCURE INC | COM | 65343E108 | 395,340 | 306,465 | SH | SOLE | 0 | 0 | 306,465 | |||
| ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 2,039,172 | 781,292 | SH | SOLE | 0 | 0 | 781,292 | |||
| PASSAGE BIO INC | COM | 702712100 | 1,354,669 | 2,058,767 | SH | SOLE | 0 | 0 | 2,058,767 | |||
| RAIN ONCOLOGY INC | COM | 75082Q105 | 62,848 | 72,926 | SH | SOLE | 0 | 0 | 72,926 | |||
| RETRACTABLE TECHNOLOGIES INC | COM | 76129W105 | 594,951 | 499,959 | SH | SOLE | 0 | 0 | 499,959 | |||
| SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | 18,364,000 | 200,000 | SH | SOLE | 0 | 0 | 200,000 | |||
| SURROZEN INC | COM | 86889P109 | 43,743 | 89,271 | SH | SOLE | 0 | 0 | 89,271 | |||
| TALARIS THERAPEUTICS INC | COM | 87410C104 | 5,620,000 | 2,000,000 | SH | SOLE | 0 | 0 | 2,000,000 | |||
| VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 582,750 | 150,000 | SH | SOLE | 0 | 0 | 150,000 | |||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 524,000 | 100,000 | SH | SOLE | 0 | 0 | 100,000 | |||